• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Lucem Health Secures $7.7M for Agnostic AI-Powered Platform

Share:

May 15, 2023

Lucem Health, a portfolio company of Mayo Clinic Platform, has successfully raised $7.7 million in a Series A venture capital funding round. Mayo Clinic, Granger Management, and Mercy (St. Louis) led the investment. Lucem Health specializes in assisting clinical AI innovators in leveraging data science to create trusted solutions that enable early disease detection, optimize care delivery, and improve patient outcomes. Their platform integrates data from various sources, connects it with AI models, and seamlessly delivers predictive insights into existing clinical workflows. The funding will be utilized to further develop Lucem Health’s platform, expand its solution portfolio, and strengthen sales and marketing efforts. Recently, the company launched Lucem Health Reveal, a suite of AI-powered solutions designed to identify patients at higher risk of serious or chronic diseases.

What You Should Know:

  • Lucem Health, a Mayo Clinic Platform portfolio company, has closed a Series A venture capital funding round of $7.7M led by Mayo Clinic, Granger Management and Mercy (St Louis).
  • Lucem Health helps clinical AI innovators transform data science into innovative, trusted solutions that can detect diseases earlier and optimize care delivery, positively impacting patient lives, improving the physician and provider experience, and ultimately producing improved outcomes.

How Lucem AI Platform Works

The Lucem Health Platform takes data from any source, normalizes and connects it to any AI model or algorithm, and delivers the resulting predictive insights seamlessly into existing clinical workflows. By embedding seamlessly into PACS, EHRs, and other data-driven workflows, the Lucem Health Platform makes it easier for hospitals, clinics, and physician practices to build, train, and scale AI models using their own data.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Expansion Plans

The funding will be used to advance development of Lucem Health’s platform for clinical AI solution deployment, grow the company’s solution portfolio and expand its sales and marketing capacity. The company recently launched Lucem Health Reveal, a family of solutions which uses AI and existing data to identify patients at higher risk of serious or chronic disease.

“AI has tremendous potential to transform and augment how physicians and providers practice medicine, make decisions and serve their patients. Yet, so far, we have barely scratched the surface of AI’s potential in healthcare,” said Sean Cassidy, founding CEO of Lucem Health. “We started Lucem Health to accelerate integration of powerful AI-generated insights into care delivery workflows in a thoughtful, responsible way. In a challenging market for raising capital, we appreciate our investors’ confidence and support.”

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sorcero Raises $10M for AI-Powered Medical Language Intelligence PlatformSorcero Raises $10M for AI-Powered Medical Language Intelligence Platform
  • Collegium to Acquire BioDelivery Sciences Broadening Pain PortfolioCollegium to Acquire BioDelivery Sciences Broadening Pain Portfolio
  • Takeda’s Shire Takeover Seen Facing EU Scrutiny of Drug ResearchTakeda’s Shire Takeover Seen Facing EU Scrutiny of Drug Research
  • Pfizer and Voyager Launch $630 Million Gene Therapy Technology PactPfizer and Voyager Launch $630 Million Gene Therapy Technology Pact
  • What does the U.S.-China trade war mean for medical device companies?What does the U.S.-China trade war mean for medical device companies?
  • Health insurance startup Angle Health scores $58MHealth insurance startup Angle Health scores $58M
  • Trump outlines new plan to lower Medicare drug  prices, end ‘rigged’ systemTrump outlines new plan to lower Medicare drug prices, end ‘rigged’ system
  • Comcast Spinoff Quil Unveils Home-Based Sensor Network for SeniorsComcast Spinoff Quil Unveils Home-Based Sensor Network for Seniors

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications